Arco J. Teske

5.2k total citations
98 papers, 2.2k citations indexed

About

Arco J. Teske is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Orthopedics and Sports Medicine. According to data from OpenAlex, Arco J. Teske has authored 98 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Cardiology and Cardiovascular Medicine, 19 papers in Radiology, Nuclear Medicine and Imaging and 18 papers in Orthopedics and Sports Medicine. Recurrent topics in Arco J. Teske's work include Cardiovascular Effects of Exercise (34 papers), Cardiovascular Function and Risk Factors (33 papers) and Chemotherapy-induced cardiotoxicity and mitigation (24 papers). Arco J. Teske is often cited by papers focused on Cardiovascular Effects of Exercise (34 papers), Cardiovascular Function and Risk Factors (33 papers) and Chemotherapy-induced cardiotoxicity and mitigation (24 papers). Arco J. Teske collaborates with scholars based in Netherlands, United Kingdom and Germany. Arco J. Teske's co-authors include Pieter A. Doevendans, Maarten J. Cramer, Niek H. J. Prakken, Folkert W. Asselbergs, Bart W.L. De Boeck, Gertjan T. Sieswerda, Paul G. Melman, Bart W. De Boeck, Birgitta K. Velthuis and Marijke Linschoten and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Arco J. Teske

88 papers receiving 2.2k citations

Peers

Countries citing papers authored by Arco J. Teske

Since Specialization

Citations

This map shows the geographic impact of Arco J. Teske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arco J. Teske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arco J. Teske more than expected).

Fields of papers citing papers by Arco J. Teske

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arco J. Teske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arco J. Teske. The network helps show where Arco J. Teske may publish in the future.

Co-authorship network of co-authors of Arco J. Teske

This figure shows the co-authorship network connecting the top 25 collaborators of Arco J. Teske. A scholar is included among the top collaborators of Arco J. Teske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arco J. Teske. Arco J. Teske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane 2025 ·Cardio-Oncology ·Marijke Linschoten, (unknown), Erik van Werkhoven, Heleen Visser-Wisselaar, Martine E.D. Chamuleau, Arco J. Teske, Lourens Robbers, Simone Oerlemans, Heleen A. Crommelin, (unknown), Astrid Schut, Folkert W. Asselbergs, Anna van Rhenen	2
2	Dexrazoxane protects against doxorubicin‐induced cardiotoxicity in susceptible human living myocardial slices: A proof‐of‐concept study 2025 ·British Journal of Pharmacology ·(unknown), (unknown), (unknown), (unknown), Ernest Diez Benavente, (unknown), (unknown), Pim van der Harst, Arco J. Teske, Andreas Dendorfer, Mostafa M. Mokhles, Pieter A. Doevendans, Teun P. de Boer, Linda W. van Laake, Joost P. G. Sluijter, (unknown)	1
3	Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicity 2025 ·Cardiovascular Research ·(unknown), (unknown), Annabelle Ballesta, Pieterjan Dierickx, (unknown), Pasquale F. Innominato, Françis Lévi, (unknown), Pieter A. Doevendans, Alwin D. R. Huitema, Arco J. Teske, Anne M. May, Joost P. G. Sluijter, Linda W. van Laake	0
4	Intracardiac echocardiography‐guided biopsies for right‐sided intracardiac tumors: An optimized diagnostic algorithm and case illustrations 2024 ·Catheterization and Cardiovascular Interventions ·Arco J. Teske, (unknown), Adriaan O. Kraaijeveld, Lysette N. Broekhuizen, Dirk van Osch, Eelke Gort, Anna van Rhenen, (unknown), Michiel Voskuil	1
5	Left Ventricle Myocardial Work Correlated with Functional Capacity in Severe Rheumatic Mitral Stenosis with Preserved Left Ventricular Ejection Fraction 2024 ·Journal of Cardiovascular Echography ·(unknown), Maarten J. Cramer, Emir Yonas, Arco J. Teske, Bambang Budi Siswanto, Pieter A. Doevendans, (unknown)	1
6	Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer 2023 ·ESMO Open ·Cornelis J.A. Punt, Volker Heinemann, Tim Maughan, Chiara Cremolini, Eric Van Cutsem, Ray McDermott, (unknown), Thierry André, Pia Österlund, Arco J. Teske, Per Pfeiffer	4
7	Plasma Proteomic Patterns Show Sex Differences in Early Concentric Left Ventricular Remodeling 2023 ·Circulation Heart Failure ·(unknown), Ernest Diez Benavente, N. Charlotte Onland‐Moret, Gideon Valstar, Maarten J. Cramer, Frans H. Rutten, Arco J. Teske, (unknown), Leonard Hofstra, Igor I. Tulevski, Nancy K. Sweitzer, G. Aernout Somsen, Hester M. den Ruijter	4
8	Global Left Ventricular Myocardial Work Efficiency in Patients With Severe Rheumatic Mitral Stenosis and Preserved Left Ventricular Ejection Fraction 2023 ·PubMed ·(unknown), (unknown), Maarten J. Cramer, Emir Yonas, Arco J. Teske, Bambang Budi Siswanto, Pieter A. Doevendans	2
9	Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients 2022 ·Biomedicines ·Mathijs O. Versteylen, Maaike Brons, Arco J. Teske, Marish I.F.J. Oerlemans	11
10	A Lumped Two-Compartment Model for Simulation of Ventricular Pump and Tissue Mechanics in Ischemic Heart Disease 2022 ·Frontiers in Physiology ·(unknown), (unknown), (unknown), Frans A. van Nieuwenhoven, Frits W. Prinzen, (unknown), (unknown), Arco J. Teske, Kevin Vernooy, Tammo Delhaas, Joost Lumens	5
11	Early Mechanical Alterations in Phospholamban Mutation Carriers 2020 ·JACC. Cardiovascular imaging ·Karim Taha, Wouter P. te Rijdt, Tom E. Verstraelen, Maarten J. Cramer, Rudolf A. de Boer, Rianne H.A.C.M. de Bruin‐Bon, Berto J. Bouma, Folkert W. Asselbergs, Arthur A.M. Wilde, Maarten P. van den Berg, Arco J. Teske	13
12	Bragatston study protocol: a multicentre cohort study on automated quantification of cardiovascular calcifications on radiotherapy planning CT scans for cardiovascular risk prediction in patients with breast cancer 2019 ·BMJ Open ·Marleen J. Emaus, Ivana Išgum, Sanne G. M. van Velzen, H.J.G.D. van den Bongard, Sofie A. M. Gernaat, Nikolas Leßmann, M. Sattler, Arco J. Teske, J. Penninkhof, Hanneke Meijer, Jean‐Philippe Pignol, Helena M. Verkooijen	16
13	Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics 2019 ·JACC CardioOncology ·(unknown), Marijke Linschoten, Maarten J. Cramer, Eelke Gort, Anna van Rhenen, Folkert W. Asselbergs, Pieter A. Doevendans, Arco J. Teske	21
14	Discovery of biomarkers for the presence and progression of left ventricular diastolic dysfunction and HEart faiLure with Preserved ejection Fraction in patients at risk for cardiovascular disease: rationale and design of the HELPFul case-cohort study in a Dutch cardiology outpatient clinic 2019 ·BMJ Open ·Gideon Valstar, Sophie H. Bots, (unknown), Aisha Gohar, Frans H. Rutten, Tim Leiner, Maarten J. Cramer, Arco J. Teske, (unknown), (unknown), Gerard Pasterkamp, Folkert W. Asselbergs, Leonard Hofstra, Michael Bots, Hester M. den Ruijter	12
15	Transthoracic Echocardiography Guided MitraClip Placement Under Conscious Sedation 2017 ·JACC: Cardiovascular Interventions ·(unknown), Arco J. Teske, Michiel Voskuil, Pieter R. Stella, Steven A. J. Chamuleau, Adriaan O. Kraaijeveld	5
16	The Slope of the Segmental Stretch-Strain Relationship as a Noninvasive Index of LV Inotropy 2013 ·JACC. Cardiovascular imaging ·Rūta Jasaitytė, Piet Claus, Arco J. Teske, Lieven Herbots, B. Verheyden, Ruxandra Jurcuţ, Frank Rademakers, Jan D’hooge	8
17	Septal Rebound Stretch Reflects the Functional Substrate to Cardiac Resynchronization Therapy and Predicts Volumetric and Neurohormonal Response 2009 ·European Journal of Heart Failure ·Bart W.L. De Boeck, Arco J. Teske, Mathias Meine, Geert E. Leenders, Maarten J. Cramer, Frits W. Prinzen, Pieter A. Doevendans	108
18	Echocardiographic Tissue Deformation Imaging Quantifies Abnormal Regional Right Ventricular Function in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy 2009 ·Journal of the American Society of Echocardiography ·Arco J. Teske, Moniek G.P.J. Cox, Bart W. De Boeck, Pieter A. Doevendans, Richard N.W. Hauer, Maarten J. Cramer	95
19	Practical and Conceptual Limitations of Tissue Doppler Imaging to Predict Reverse Remodelling in Cardiac Resynchronisation Therapy 2008 ·European Journal of Heart Failure ·Bart W.L. De Boeck, Mathias Meine, Geert E. Leenders, Arco J. Teske, Harry van Wessel, J. H. Kirkels, Frits W. Prinzen, Pieter A. Doevendans, Maarten J. Cramer	55
20	Echocardiographic Assessment of Regional Right Ventricular Function: A Head-to-head Comparison Between 2-Dimensional and Tissue Doppler–derived Strain Analysis 2007 ·Journal of the American Society of Echocardiography ·Arco J. Teske, Bart W.L. De Boeck, M. A. G. M. Olimulder, Niek H. J. Prakken, Pieter A. Doevendans, Maarten J. Cramer	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact